PrairieView Partners’s AbbVie ABBV Stock Holding History

PrairieView Partners’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$19K	Hold	106	–	–	﹤0.01%	249
2025 Q1	$22K	Hold	106	–	–	﹤0.01%	226
2024 Q4	$18K	Sell	106 -2	-2%	-$368	﹤0.01%	253
2024 Q3	$21K	Hold	108	–	–	﹤0.01%	241
2024 Q2	$18K	Hold	108	–	–	﹤0.01%	257
2024 Q1	$20K	Buy	108 +6	+6%	+$1.03K	﹤0.01%	239
2023 Q4	$16K	Sell	102 -193	-65%	-$28.1K	﹤0.01%	251
2023 Q3	$43K	Sell	295 -40	-12%	-$5.87K	0.01%	188
2023 Q2	$45K	Buy	335 +260	+347%	+$38.1K	0.01%	202
2023 Q1	$11K	Hold	75	–	–	﹤0.01%	296
2022 Q4	$12K	Sell	75 -33	-31%	-$5.06K	﹤0.01%	298
2022 Q3	$14K	Sell	108 -982	-90%	-$141K	﹤0.01%	276
2022 Q2	$167K	Buy	1,090 +361	+50%	+$55.2K	0.03%	109
2022 Q1	$118K	Buy	729 +41	+6%	+$5.96K	0.02%	138
2021 Q4	$93K	Buy	+688	New	+$81.3K	0.01%	158
2020 Q4	–	Sell	-100	Closed	-$9K	–	308
2020 Q3	$9K	Buy	+100	New	+$9.41K	﹤0.01%	242

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

PrairieView Partners's ABBV Position: Q2 2025 in Review

PrairieView Partners held its AbbVie (ABBV) position steady in Q2 2025 at 106 shares worth $19K. The position accounts for ﹤0.01% of the portfolio, ranked #249.

PrairieView Partners first reported a position in ABBV in Q3 2020 and has held it in 16 quarters since. The position peaked at $167K in Q2 2022. 3,780 funds tracked by Wall St. Rank hold ABBV as of Q2 2025.

PrairieView Partners held 106 shares of AbbVie worth $19K as of Q2 2025.
PrairieView Partners left its AbbVie share count unchanged in Q2 2025.
AbbVie made up ﹤0.01% of PrairieView Partners's portfolio in Q2 2025, its #249 holding.
PrairieView Partners first reported a position in AbbVie in Q3 2020 and has held it in 16 quarters since.
PrairieView Partners's AbbVie position peaked at $167K in Q2 2022.
3,780 funds tracked by Wall St. Rank held AbbVie as of Q2 2025.

Based on PrairieView Partners's 13F filing for Q2 2025, filed 25 Jul 2025.